It's in the Fine Print | GenomeWeb

The success of companies such as 23andMe and Navigenics hinges on good data security, says Blaine Bettinger at the Genetic Genealogist. "A single security breach could potentially drive away future customers," he blogs. Bettinger also points to Ryan Calo's discussion of a panel at Stanford.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.